Formulated product
Zolmitriptán Normon 5 mg comprimidos bucodispersables EFG.
Formulated product. The registry describes a specific formulation. Its exact chemical ingredients and approval status require separate evidence.
1 studies reference this formulated product.
1 studies mention this registry entry. Counts describe the source entry and do not establish exposure to an individual molecule.
Success Metrics
Active Trials
0(0%)
Phase Distribution
Ph phase_1
1
100%
Phase Distribution
1
Early Stage
0
Mid Stage
0
Late Stage
Phase Distribution1 total trials
Phase 1Safety & dosage
1(100.0%)
Highest Phase Reached
Phase 1Trial Status & Enrollment
Completion Rate
0.0%
0 of 0 finished
Non-Completion Rate
0.0%
0 ended early
Currently Active
0
trials recruiting
Total Trials
1
all time
Status Distribution
Other(1)
Detailed Status
unknown1
Development Timeline
Analytics
Development Status
Total Trials
1
Active
0
Success Rate
N/A
Most Advanced
Phase 1
Trials by Phase
Phase 11 (100.0%)
Trials by Status
unknown1100%
Recent Activity
Clinical Trials (1)
Drug Details
- Intervention Type
- Type not reported
- Total Trials
- 1